Get started
Author

Lisa M. Sweeney

Observed names: L Sweeney, L. M. Sweeney, L. Sweeney, L.M Sweeney, L.M. Sweeney, Lisa M Sweeney, Lisa Sweeney, Sweeney, Lisa M.
Observed institutions: Henry M. Jackson Foundation, United States Air Force Research Laboratory, Johns Hopkins University, GlaxoSmithKline (United Kingdom), Cornell University, Wright-Patterson Air Force Base, Concurrent Technologies Corporation, Aerogen (Ireland), Dayton School District, New Hanover Regional Medical Center, UES (United States), Shell (United Kingdom), Towson University, 711th Human Performance Wing, Toxicology Excellence for Risk Assessment, Naval Medical Research Unit DAYTON, BlueHalo (United States), GlaxoSmithKline Research & Development Limited (United Kingdom), ExxonMobil (United States)
ORCID: 0000-0002-4672-7358
Observed ORCID: 0000-0002-4672-7358
OpenAlex ID: A5013772689
36th International Symposium on Intensive Care and Emergency Medicine
2016 · R. M. Bateman, M. D. Sharpe, et al. · Critical Care · 535
PDF
In Vitro Metabolism of 8-2 Fluorotelomer Alcohol: Interspecies Comparisons and Metabolic Pathway Refinement
2007 · Diane L. Nabb, Bogdan Szostek, et al. · Toxicological Sciences · 141
Estimation of safe dietary intake levels of acrylamide for humans
2009 · Robert G. Tardiff, Michael L. Gargas, et al. · Food and Chemical Toxicology · 140
IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making
2022 · Xiaoqing Chang, Yu-Mei Tan, et al. · Toxics · 131
PDF
Advances in Inhalation Dosimetry Models and Methods for Occupational Risk Assessment and Exposure Limit Derivation
2015 · Eileen D. Kuempel, Lisa M. Sweeney, et al. · Journal of Occupational and Environmental Hygiene · 117
A Randomized, Placebo‐Controlled Study of the Effects of the p38 MAPK Inhibitor SB‐681323 on Blood Biomarkers of Inflammation in COPD Patients
2009 · Dave Singh, Lucy Smyth, et al. · The Journal of Clinical Pharmacology · 108
Bronchodilatory Effect of the PPAR-γ Agonist Rosiglitazone in Smokers With Asthma
2009 · M Spears, I Donnelly, et al. · Clinical Pharmacology & Therapeutics · 88
A cell culture analogue of rodent physiology: Application to naphthalene toxicology
1995 · L.M. Sweeney, M.L. Shuler, et al. · Toxicology in Vitro · 84
Kinetics of 8-2 fluorotelomer alcohol and its metabolites, and liver glutathione status following daily oral dosing for 45 days in male and female rats
2009 · William J. Fasano, Lisa M. Sweeney, et al. · Chemico-Biological Interactions · 83
Physiologically Based Pharmacokinetic Model Use in Risk Assessment—Why Being Published Is Not Enough
2011 · Eva D. McLanahan, Hisham A. El-Masri, et al. · Toxicological Sciences · 71
Proposed Occupational Exposure Limits for Select Ethylene Glycol Ethers Using PBPK Models and Monte Carlo Simulations
2001 · L. M. Sweeney, T. R. Tyler, et al. · Toxicological Sciences · 64
1,3-Butadiene: I. Review of metabolism and the implications to human health risk assessment
2010 · Christopher R. Kirman, Richard J. Albertini, et al. · Critical Reviews in Toxicology · 61
Physiologically based pharmacokinetic modeling of 1,3-butadiene, 1,2- epoxy-3-butene, and 1,2:3,4-diepoxybutane toxicokinetics in mice and rats
1997 · L. Sweeney · Carcinogenesis · 54
Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling
2003 · C.R Kirman, L.M Sweeney, et al. · Regulatory Toxicology and Pharmacology · 53
A Toxicokinetic Study of Inhaled Ethylene Glycol Monomethyl Ether (2-ME) and Validation of a Physiologically Based Pharmacokinetic Model for the Pregnant Rat and Human
2000 · Michael L. Gargas, Tipton R. Tyler, et al. · Toxicology and Applied Pharmacology · 51
Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats
2015 · Lisa M. Sweeney, Laura MacCalman, et al. · Regulatory Toxicology and Pharmacology · 44
A Toxicokinetic Study of Inhaled Ethylene Glycol Ethyl Ether Acetate and Validation of a Physiologically Based Pharmacokinetic Model for Rat and Human
2000 · Michael L. Gargas, Tipton R. Tyler, et al. · Toxicology and Applied Pharmacology · 44
The Association Between Poor Sleep and the Incidence of Sport and Physical Training-Related Injuries in Adult Athletic Populations: A Systematic Review
2021 · Devon A. Dobrosielski, Lisa Sweeney, et al. · Sports Medicine · 42
Development of a physiologically-based toxicokinetic model of acrylamide and glycidamide in rats and humans
2009 · Lisa M. Sweeney, Christopher R. Kirman, et al. · Food and Chemical Toxicology · 41
Physiologically Based Pharmacokinetic Model Parameter Estimation and Sensitivity and Variability Analyses for Acrylonitrile Disposition in Humans
2003 · L. M. Sweeney · Toxicological Sciences · 40
Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion
2009 · M.L. Gargas, C.R. Kirman, et al. · Food and Chemical Toxicology · 39
The Efficacy and Tolerability of Two Novel H1/H3 Receptor Antagonists in Seasonal Allergic Rhinitis
2011 · Peter Daley-Yates, Claire Ambery, et al. · International Archives of Allergy and Immunology · 33
Propylene Oxide: Genotoxicity Profile of a Rodent Nasal Carcinogen
2007 · Richard J. Albertini, Lisa M. Sweeney · Critical Reviews in Toxicology · 29
Comparison of PBTK model and biomarker based estimates of the internal dosimetry of acrylamide
2013 · R.S. DeWoskin, L.M. Sweeney, et al. · Food and Chemical Toxicology · 28
Development of a physiologically based pharmacokinetic (PBPK) model for methyl iodide in rats, rabbits, and humans
2009 · Lisa M. Sweeney, Christopher R. Kirman, et al. · Inhalation Toxicology · 27
Works count: 250
Citation count: 3,846
H-index: 27
I10-index: 59
Year
Topic
Type